Leukotriene B4 omega-side chain hydroxylation by CYP4F5 and CYP4F6
about
Functional polymorphism in human CYP4F2 decreases 20-HETE production20-Hydroxylation is the CYP-dependent and retinoid-inducible leukotriene B4 inactivation pathway in human and mouse skin cellsCYP1A in TCDD toxicity and in physiology-with particular reference to CYP dependent arachidonic acid metabolism and other endogenous substrates.Evidence that 20-HETE contributes to the development of acute and delayed cerebral vasospasm.Human cytochrome p450 family 4 enzymes: function, genetic variation and regulation.Catalytic characterization and cytokine mediated regulation of cytochrome P450 4Fs in rat hepatocytesMolecular mechanisms and cell signaling of 20-hydroxyeicosatetraenoic acid in vascular pathophysiology.Pressure-induced myogenic tone and role of 20-HETE in mediating autoregulation of cerebral blood flow.Expression of CYP 4A ω-hydroxylase and formation of 20-hydroxyeicosatetreanoic acid (20-HETE) in cultured rat brain astrocytes.CYP4Fs expression in rat brain correlates with changes in LTB4 levels after traumatic brain injury.Urinary metabolites of leukotriene B4 in the human subject.Inflammatory prompts produce isoform-specific changes in the expression of leukotriene B(4) omega-hydroxylases in rat liver and kidney.Expression of CYP4F12 in gastrointestinal and urogenital epithelia.
P2860
Q24299206-1A15F9E7-7C68-4DC2-858A-72A9C392FEEAQ34982901-5A25B461-6D6F-48F7-9321-78DADD291E4FQ36473507-6906D45E-420D-4F4E-A646-AC97045DBECAQ36681479-7893771F-2FBF-4EA6-8B85-159EE56C9D3FQ36929610-4D250940-6D8F-4679-82B8-77A723A15EA1Q36951768-22E23D35-8B7C-41DF-82E2-9994D7D9828FQ37340856-61250611-DB30-479B-B6DF-7F85FE274451Q37831746-D048E2E9-4D07-4820-A877-5C956A7261EAQ41877912-AB570D37-22DC-41D8-98E2-F8BFACFE936AQ42128844-EF51D555-72D3-4D2F-92AE-17F944BDED37Q44412878-A6FEE5A6-093E-4362-AE24-40AE899DC859Q44673362-D0487D46-C277-462D-9170-BB0AB5F3F861Q44839908-2F105926-DE19-42D1-80A0-195498948AF6
P2860
Leukotriene B4 omega-side chain hydroxylation by CYP4F5 and CYP4F6
description
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2003
@ast
im April 2003 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2003/04/01)
@sk
vědecký článek publikovaný v roce 2003
@cs
wetenschappelijk artikel (gepubliceerd op 2003/04/01)
@nl
наукова стаття, опублікована у квітні 2003
@uk
مقالة علمية (نشرت في أبريل 2003)
@ar
name
Leukotriene B4 omega-side chain hydroxylation by CYP4F5 and CYP4F6
@ast
Leukotriene B4 omega-side chain hydroxylation by CYP4F5 and CYP4F6
@en
Leukotriene B4 omega-side chain hydroxylation by CYP4F5 and CYP4F6
@nl
type
label
Leukotriene B4 omega-side chain hydroxylation by CYP4F5 and CYP4F6
@ast
Leukotriene B4 omega-side chain hydroxylation by CYP4F5 and CYP4F6
@en
Leukotriene B4 omega-side chain hydroxylation by CYP4F5 and CYP4F6
@nl
prefLabel
Leukotriene B4 omega-side chain hydroxylation by CYP4F5 and CYP4F6
@ast
Leukotriene B4 omega-side chain hydroxylation by CYP4F5 and CYP4F6
@en
Leukotriene B4 omega-side chain hydroxylation by CYP4F5 and CYP4F6
@nl
P2093
P1476
Leukotriene B4 omega-side chain hydroxylation by CYP4F5 and CYP4F6
@en
P2093
Adam G. Harder
David R. Harder
Johan Bylund
Kristopher G. Maier
Richard J. Roman
P356
10.1016/S0003-9861(03)00030-4
P407
P577
2003-04-01T00:00:00Z